Power and Photobiomodulation

Written By: Alon Landa
Reviewed: [April 2026]
Updated: [April 2026]

I like my light like I like my coffee. Strength matters, but too much ruins the brew.

Quick Take

  • Wavelength tells light where to go.
  • Power tells light what to do once it gets there.
  • Average power, not flashy peak power, drives healing.
  • Stay under ~300 mW/cm² and hit 4–8 J/cm² per spot for most conditions.
  • Using higher power levels by cranking the dial past that sweet spot can stall—or even reverse—results.

How does power affect the effectiveness of photobiomodulation?

Power determines how light interacts with tissue once it reaches the target, directly influencing the biological response. Moderate average power levels drive healing by delivering effective energy doses, while excessive intensity can stall or even reverse results due to the biphasic dose response. Staying within an optimal range—typically under about 300 mW/cm² with appropriate energy dosing—produces the most consistent therapeutic outcomes.

Introduction to Photobiomodulation

Photobiomodulation (PBM) is a cutting-edge, non-invasive therapy that harnesses the power of light to support the body’s natural healing process. Using low level laser therapy or specialized LEDs, PBM delivers targeted wavelengths—most often in the red or near-infrared spectrum—directly to the skin and underlying tissues. These wavelengths are carefully chosen because they’re readily absorbed by cells, setting off a cascade of photochemical events that enhance normal cellular function.

When light energy reaches the body, it’s absorbed by molecules within the cells, boosting blood flow, reducing inflammation, and encouraging the production of key molecules needed for tissue repair. This process has been shown to promote wound healing, stimulate hair growth, and support tissue regeneration. Whether you’re looking to manage pain, speed up recovery, or simply help your pet feel their best, PBM offers a gentle, drug-free approach that works in harmony with the human body’s own biology.

Power 101: Goldilocks, Not Hulk

Think of PBM like medicine. As a non-invasive therapy, PBM has the ability to induce biological effects such as hair growth, wound healing, and pain reduction. The biphasic dose response says too little light does nothing, too much can suppress healing, and the just-right dose unleashes tissue repair Hashmi 2010 🔗. PBM uses specialized LEDs, but also incorporates different light sources—including lasers and broadband light—and PBM devices come in various forms. These light sources deliver non-ionizing light to underlying tissues, acting at different biological scales, from the cellular to tissue level. We chase precision, not brute force.

PBM works by delivering specific wavelengths of light that interact with chromophores like cytochrome c oxidase and other molecules within the cells. This interaction can produce energy and activate biological processes, encouraging the production of key molecules needed for tissue repair, and is used to treat a variety of conditions in the human body.

Mechanism of Action

At the heart of photobiomodulation therapy is the interaction between light and the body’s own molecules—specifically, endogenous chromophores like cytochrome c oxidase. When red light or near-infrared wavelengths are absorbed by these chromophores, they trigger a series of biological reactions that ramp up cellular energy production. This boost in energy metabolism leads to improved blood flow, better tissue oxygenation, and a reduction in inflammation.

The effects of PBM are wide-ranging: it can stimulate hair growth, accelerate wound healing, and provide relief from chronic pain. Research shows that shorter wavelengths, such as red light, are especially effective for treating superficial tissues, while longer, near-infrared wavelengths penetrate deeper to reach muscles and joints. Recent research has led researchers to explore even more applications for PBM, from managing inflammation to supporting tissue regeneration and pain relief. The science is clear—when the right light reaches the right tissue, the results can be fantastic.

Peak vs Average Power

Peak power is the billboard number. However, using only one wavelength or one set of parameters is not universally effective—treatment should be tailored to the target tissue to ensure optimal results. Average power is the paycheck your cells actually cash. A super-pulsed laser might boast 50 W peaks yet average 60 mW, far less than a steady 0.5 W LED Hashmi 2010 🔗. Cells “see” the average. Peaks mostly add heat or a temporary nerve block.

The Penetration Myth

Does double the wattage go twice as deep? Not even close. Studies show that upping continuous-wave irradiance above 2 W/cm² adds only ~10 % extra depth while spiking thermal risk Hashmi 2010 🔗, Tedford 2015 🔗.

Want photons where they count?

  1. Right wavelength (600–850 nm).
  2. Skin contact & gentle pressure.
  3. Consistent delivery.Before starting treatment, always assess for visible signs on the skin, such as lesions, to rule out serious conditions. While natural sunlight also provides therapeutic benefits for pets, its penetration and effects differ from targeted light therapy. Power inflation is the wrong tool for the job.

Power Density (Irradiance): The Pressure Gauge

The Biphasic Curve in Real Life

Lanzafame’s pressure-ulcer model: same 5 J/cm² dose closed wounds fastest at mid-range power; highest power slowed repair Lanzafame 2007 🔗. Translation? Power + time = effective dose. Get either wrong and you miss the mark. It’s crucial to evaluate each patient’s response to therapy, as researchers often lead with plausible molecular mechanisms that must be validated in clinical settings before assuming clinical success.

At-Home Advantage: Why Steady Beats Spiky

Chronic issues—arthritis, IVDD, wound care—need repeated treatments in the cellular sweet spot. Moderate-power LED pads used daily often outperform clinic-only high-power lasers because consistency wins the race.

Safety and Precautions

Photobiomodulation therapy is widely regarded as safe, with minimal side effects reported in the scientific literature. Still, as with any treatment, it’s important to take a few precautions. Individuals with certain medical conditions—like epilepsy or those with pacemakers—should consult their healthcare provider before starting PBM. It’s also essential to avoid shining the light directly into the eyes or over tattoos, as these areas can react differently to treatment. For best results, the skin should be clean and free of lotions or makeup to maximize light absorption.

While more research is needed to fully understand the long-term effects of PBM, current evidence supports its safety and effectiveness for a variety of conditions. As always, following recommended guidelines and consulting with a clinician can help ensure the best possible outcome from your therapy.

Comparison to Other Treatments

Photobiomodulation therapy stands out as a non-invasive, drug-free alternative to traditional treatments like pharmaceuticals or even some forms of low level laser therapy. Clinical trials have shown that PBM can be just as effective—if not more so—for managing chronic pain, stimulating hair growth, and promoting wound healing, all without the risks of side effects or dependency that can come with medication.

Unlike treatments that rely on heat or chemicals, PBM uses light to gently activate the body’s own repair mechanisms. It can also be combined with other therapies, such as physical therapy or medication, to enhance overall results. The National Library of Medicine recognizes PBM as a legitimate treatment option, and ongoing research continues to expand its potential uses. As the science behind PBM grows, more patients and pet parents are discovering its benefits for everything from tissue repair to hair growth and pain relief—making it a fantastic addition to the modern healing toolkit.

Prove It

Claim

Key Evidence

Take-Home

Doubling power barely extends depth

Hashmi 2010; Tedford 2015

Focus on contact & wavelength, not wattage bragging rights.

Average power drives biology

Hashmi 2010

Cells integrate total fluence, not millisecond spikes. These effects are observed across various biological scales, from molecular to cellular levels.

Healing sweet spot < 300 mW/cm²

Chung 2012; de Freitas 2016

Stay in the “whisper” zone for ATP boost & anti-inflammatory effects, engaging a cast of molecular players in the healing process.

Too much power reverses gains

Sharma 2011

Overshoot = oxidative stress, slower repair.

Citation Summary

  • Low-level laser therapy improves early healing of medial collateral ligament injuries in rats

    By Bayat et al.

    • 2005

    • Journal: Photomed Laser Surg

    Abstract: “The ultimate tensile strength (UTS) of group 2 on day 12 was significantly higher than that of groups 1 and 3.” Comment: The dose of 0.01J/cm2 was ineffective, while 1.20J/cm2 was effective. Too small dose does often have no effect.

    One Sentence Outcome:In rats with medial collateral ligament injury, LLLT improved early ultimate tensile strength, supporting ligament-healing and tissue-strength claims.

    Study Parameters:Dose response

    Device Parameters: wavelength: 633; power: 10; fluence: 0.01 1.20; sessions: 21

    Evidence Level:Level 5 (preclinical animal study)

    Study Type: Rat

    Outcome Direction: Positive / early ligament strength

  • Comparison of single and multiple applications of GaAlAs laser on rat medial collateral ligament repair

    By Ng et al.

    • 2004

    • Journal: Lasers Surg Med

    Abstract: “Multiple laser therapy improves the normalized strength and stiffness of repairing rat MCLs at 3 weeks after injury. The multiple treatments seem to be superior to a single treatment when the cumulative dosages are comparable between the two modes of application.”

    One Sentence Outcome:In rat MCL repair, multiple GaAlAs laser applications improved normalized strength and stiffness more than a single treatment, supporting treatment-frequency relevance.

    Study Parameters:Single vs multiple treatments (dose response)

    Device Parameters: wavelength: 660; power: 2016-08-08 00:00:00; fluence: 31.6; sessions: 1 9

    Evidence Level:Level 5 (preclinical animal study)

    Study Type: Rat

    Outcome Direction: Positive / multiple treatments superior

  • Low level laser therapy induces increased viability and proliferation in isolated cancer cells

    By Kara C; Selamet H; Gökmenoğlu C; Kara N

    • 2018

    • Journal: Cell Proliferation

    Abstract: The study evaluated effects of LLLT on osteosarcoma-like and lung carcinoma cell lines. Proliferation increased with additional applications and higher power output levels, leading the authors to caution that LLLT may activate precancerous cells or increase existing cancerous tissue in clinically undetected situations.

    One Sentence Outcome:LLLT increased cancer-cell proliferation in vitro depending on power output and number of applications.

    Study Parameters:Saos-2 osteoblast-like osteosarcoma cells and A549 human lung carcinoma cells were irradiated and cell proliferation was measured by MTT assay.

    Device Parameters: Nd:YAG laser; power outputs of 0.5, 1, 2, and 3 W; one to three irradiations according to test group.

    Evidence Level:Mechanistic safety signal

    Study Type: In vitro dose/application study

    Outcome Direction: Cautionary / increased cell proliferation

  • Low-level laser therapy stimulates proliferation in head and neck squamous cell carcinoma cells

    By Bamps M; Dok R; Nuyts S

    • 2018

    • Journal: Frontiers in Oncology

    Abstract: In vitro study examining LLLT effects on head and neck squamous cell carcinoma cells. The authors reported that LLLT increased proliferation in a dose-dependent manner in HNSCC cells but not in normal epithelial tonsil cells.

    One Sentence Outcome:LLLT stimulated dose-dependent proliferation in head and neck squamous cell carcinoma cells, supporting caution around malignant tissue.

    Study Parameters:Head and neck squamous cell carcinoma cells and normal epithelial tonsil cells were exposed to LLLT and evaluated for proliferation response.

    Device Parameters: Low-level laser therapy; dosing parameters varied in vitro.

    Evidence Level:Mechanistic safety signal

    Study Type: In vitro dose-response study

    Outcome Direction: Cautionary / dose-dependent proliferation

  • Low-level laser on femoral growth plate in rats

    By de Oliveira SP; Rahal SC; Pereira EJ; Bersano PR; Vieira FA; Padovani CR

    • 2012

    • Journal: Acta Cirúrgica Brasileira

    Abstract: Animal study evaluating influence of LLLT on the femoral growth plate in young rats. The protocol used 830 nm GaAlAs laser irradiation at the distal femoral growth plate and assessed growth-plate outcomes versus sham exposure.

    One Sentence Outcome:A young-rat growth-plate study supports a conservative approach to PBM near open growth plates in juvenile animals.

    Study Parameters:Thirty 40-day-old male Wistar rats were divided into laser and sham groups; the distal growth plate of the right femur was irradiated and compared with controls.

    Device Parameters: GaAlAs laser; 830 nm; 40 mW; 10 J/cm²; daily irradiation for up to 21 days.

    Evidence Level:Preclinical animal safety signal

    Study Type: Controlled animal study

    Outcome Direction: Cautionary / growth plate response

  • Effect of GaAlAs laser irradiation on the epiphyseal cartilage of rats

    By Cressoni MDC; Casarotto RA; De Oliveira S; et al.

    • 2010

    • Journal: Photomedicine and Laser Surgery

    Abstract: Preclinical rat study evaluating an 830 nm GaAlAs diode laser on epiphyseal cartilage. Histological analysis and radiographs showed increased epiphyseal cartilage thickness and increased chondrocyte number in laser groups, although total bone length did not change.

    One Sentence Outcome:830 nm GaAlAs laser altered epiphyseal cartilage thickness and chondrocyte number in rats, supporting caution near active growth plates.

    Study Parameters:Rat epiphyseal cartilage was exposed to 830 nm GaAlAs laser and evaluated by histological analysis and x-ray radiographs for cartilage thickness, chondrocyte count, and bone length.

    Device Parameters: 830 nm GaAlAs diode laser; 5 and 15 J/cm² dose groups.

    Evidence Level:Preclinical animal safety signal

    Study Type: Controlled animal study

    Outcome Direction: Cautionary / cartilage changes

  • The effects of low-level laser therapy, 670 nm, on epiphyseal growth in rats

    By de Andrade AR; Casarotto RA; et al.

    • 2012

    • Journal: Photomedicine and Laser Surgery

    Abstract: Preclinical rat study evaluating 670 nm LLLT on epiphyseal growth. The study concluded that treatment under the tested parameters caused neither changes in epiphyseal cartilage areas nor final limb length.

    One Sentence Outcome:This rat model found no growth-plate changes with 670 nm LLLT under the tested parameters, but it still belongs in a juvenile-growth safety evidence stack.

    Study Parameters:Rat tibial growth plates were treated with 670 nm LLLT and assessed radiologically and histologically for epiphyseal cartilage area and final limb length.

    Device Parameters: 670 nm low-level laser therapy; parameters applied to rat tibial growth plate.

    Evidence Level:Preclinical animal safety study

    Study Type: Controlled animal study

    Outcome Direction: No observed growth-plate change under tested parameters

  • Transcutaneous transmission of photobiomodulation light to the spinal canal of dog as measured from cadaver dogs using a multi-channel intra-spinal probe.

    By Piao et al.

    • 2019

    • Journal: Lasers Med Sci

    Abstract:

    One Sentence Outcome:Transcutaneous PBM light reached the spinal canal in dog cadavers, supporting the plausibility of spinal light delivery.

    Study Parameters:

    Device Parameters: wavelength: 980 nm

    Evidence Level:Experimental veterinary cadaver study

    Study Type: Dog cadaver

    Outcome Direction:

  • Low-level laser therapy prevents degenerative morphological changes in an experimental model of anterior cruciate ligament transection in rats

    By Bublitz et al.

    • 2014

    • Journal: Lasers Med Sci

    Abstract: “Initial signs of tissue degradation were observed in CG. Interestingly, laser-treated animals presented a better tissue organization, especially at the fluence of 10 J/cm(2). Furthermore, laser phototherapy was able of modulating some of the aspects related to the degenerative process, such as the prevention of proteoglycans loss and the increase in cartilage area. However, LLLT was not able of modulating chondrocytes proliferation and the immunoexpression of markers related to inflammatory process (IL-1 and MMP-13). This study showed that 808 nm laser, at both fluences, prevented features related to the articular degenerative process in the knees of rats after ACLT.”

    One Sentence Outcome:In a rat ACL-transection model, PBM helped preserve tissue organization and cartilage-related structure, supporting a biological rationale for ligament-related recovery support.

    Study Parameters:Ligament transection; ; Biphasic dose response

    Device Parameters: wavelength: 808; fluence: 10 50; sessions: 15

    Evidence Level:Level 5 (preclinical animal study)

    Study Type: Rat

    Outcome Direction: Positive / dose-dependent preclinical signal

  • Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials

    By Chow RT; Johnson MI; Lopes-Martins RAB; Bjordal JM

    • 2009

    • Journal: The Lancet

    Abstract: Meta-analysis of randomized controlled trials evaluating low-level laser therapy for neck pain, reporting reductions in acute pain and sustained benefit in chronic neck pain after treatment.

    One Sentence Outcome:LLLT reduced neck pain immediately after treatment and showed sustained benefit in chronic neck pain.

    Study Parameters:Systematic review and meta-analysis of LLLT for acute and chronic neck pain.

    Device Parameters: LLLT parameters varied across randomized placebo or active-control trials.

    Evidence Level:Meta-analysis of randomized trials

    Study Type: Systematic review and meta-analysis

    Outcome Direction: Positive

About the Author
Alon Landa is the CEO and co-founder of MedcoVet, a leader in at-home red light therapy for pets. With over 20 years of experience in medical technology and firsthand involvement in developing the Luma, Alon combines deep technical knowledge with a passion for improving pet health. He regularly collaborates with veterinarians and pet parents to advance photobiomodulation (PBM) care at home.
 📍 Based in Boston, MA
📖Read more from Alon here

🐾 Ready to Take the Next Step?
Whether you’re just learning or ready to act — we’ve got you.

👉 Book a Free Consult
 Talk to a licensed clinician about your pet’s condition and get a personalized plan. No pressure, just real help.

👉Learn More About the Luma
 Explore how our at-home red light therapy device works, why it’s different, and what it can do for your pet.

Similar Posts